Akebia Therapeutics Reports Second Quarter 2019 Financial Results and Hosts Conference Call to Discuss Recent Business Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. IBM
2. SPY
3. LCID
4. JPM
5. ERAS
6. BAC
7. TREX
8. AAPL
9. WFC
10. ORCL

Go back to Akebia Therapeutics Reports Second Quarter 2019 Financial Results and Hosts Conference Call to Discuss Recent Business Highlights

Akebia Therapeutics (AKBA) Misses Q2 EPS by 17c

August 8, 2019 8:07 AM EDT

Akebia Therapeutics (NASDAQ: AKBA) reported Q2 EPS of ($0.49), $0.17 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $100.8 million versus the consensus estimate of $91.13 million.

For earnings history and earnings-related data on Akebia Therapeutics (AKBA) click here.

... More